Neural cell death occurs in many retinal degenerations including AMD. Although partial therapies exist for the """"""""wet"""""""" form of AMD there is no effective therapy for the """"""""dry"""""""" form, which is characterized by progressive loss of retinal pigment epithelial cells and photoreceptors. Thus, effective neuroprotection is urgently needed but unfortunately there are no effective treatments currently available. Although apoptosis has been shown to be a major form of cell death, interventions based solely on inhibition of this important modality have failed to achieve the desired goal. We recently demonstrated that RIP kinase-mediated necrosis (also known as necroptosis) in addition to caspase-dependent apoptosis is involved in photoreceptor death in a retinal detachment model of retinal degeneration and that effective neuroprotection necessitates combination therapy. We propose to study whether the RIP kinase pathway in combination with caspases can be a novel therapeutic target in other animal models of retinal degeneration such as AMD. Yang et al (NEJM 2008) identified TLR3 polymorphism to be associated with AMD and that PolyI:C (analog of dsRNA) mediated activation of TLR 3 in animals leads to atrophic AMD like changes. Additionally, several studies from us and other laboratories have shown that bone-marrow (BM) derived macrophages/microglia significantly contribute to retinal degeneration in animal models. We have seen that RIP3-/- genetic deletion decreases inflammatory infiltrate but it remains unanswered if RIP3-/- deletion from all cells or from immune cells can suffice for neuroprotection. We propose to expand our findings on the redundancy of cell death pathways from the retinal detachment model to animal models of AMD by evaluating the neuroprotective effects of RIPK and Caspase Inhibition (alone and in combination) in the Poly I:C model of AMD. In addition to further examine the mechanism of neuroprotection we will study the role of immune system in the mechanism of RIP3-/- neuroprotection in the poly I:C model of retinal toxicity by performing Bone Marrow Transplant (BMT) between WT and RIP3-/- mice.
Dry AMD affects millions of people in the USA and there is no effective treatment. Loss and cell death of photoreceptors is the major cause of the visual decline seen in this disease. Our work has uncovered novel redundant parallel cell death pathways in animal models of this disease and is identifying molecules to successfully interfere with them. These findings may lead to development of new drugs that can be used to help patients with dry AMD.
|Paschalis, Eleftherios I; Lei, Fengyang; Zhou, Chengxin et al. (2018) Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries. J Immunol :|
|Kosmidou, Cassandra; Efstathiou, Nikolaos E; Hoang, Mien V et al. (2018) Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration. Sci Rep 8:461|
|Paschalis, Eleftherios I; Lei, Fengyang; Zhou, Chengxin et al. (2018) Permanent neuroglial remodeling of the retina following infiltration of CSF1R inhibition-resistant peripheral monocytes. Proc Natl Acad Sci U S A 115:E11359-E11368|
|Diaz, J Daniel; Wang, Jay C; Oellers, Patrick et al. (2018) Imaging the Deep Choroidal Vasculature Using Spectral Domain and Swept Source Optical Coherence Tomography Angiography. J Vitreoretin Dis 2:146-154|
|Tsoka, Pavlina; Matsumoto, Hidetaka; Maidana, Daniel E et al. (2018) Effects of BNN27, a novel C17-spiroepoxy steroid derivative, on experimental retinal detachment-induced photoreceptor cell death. Sci Rep 8:10661|
|Paschalis, Eleftherios I; Zhou, Chengxin; Lei, Fengyang et al. (2017) Mechanisms of Retinal Damage after Ocular Alkali Burns. Am J Pathol 187:1327-1342|
|Tian, Bo; Al-Moujahed, Ahmad; Bouzika, Peggy et al. (2017) Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells. Sci Rep 7:2329|
|Ying, Ying; Ueta, Takashi; Jiang, Shanshan et al. (2017) Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK. Oncotarget 8:32794-32806|
|Laíns, Inês; Duarte, Daniela; Barros, António S et al. (2017) Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy. PLoS One 12:e0177749|
|Al-Moujahed, Ahmad; Brodowska, Katarzyna; Stryjewski, Tomasz P et al. (2017) Verteporfin inhibits growth of human glioma in vitro without light activation. Sci Rep 7:7602|
Showing the most recent 10 out of 36 publications